Benefit risk considerations for African swine fever virus live attenuated vaccines
NPJ Vaccines
.
2025 Jul 7;10(1):147.
doi: 10.1038/s41541-025-01208-8.
Authors
Sandra Blome
1
,
Virginia Friedrichs
2
,
Alexander Schäfer
2
,
Martin Beer
2
Affiliations
1
Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Greifswald, Insel Riems, Germany. sandra.blome@fli.de.
2
Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Greifswald, Insel Riems, Germany.
PMID:
40624001
DOI:
10.1038/s41541-025-01208-8
No abstract available
Publication types
Letter
Grants and funding
101136676 - ASFaVIP/HORIZON EUROPE Framework Programme
101136676 - ASFaVIP/HORIZON EUROPE Framework Programme
101136676 - ASFaVIP/HORIZON EUROPE Framework Programme
101136676 - ASFaVIP/HORIZON EUROPE Framework Programme